1 Pharmacogenetics Section, Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden. Electronic address: magnus.ingelman-sundberg@ki.se.
2 Molecular Neuropsychiatry Research Branch, NIDA Intramural Research Program, National Institutes of Health, Baltimore, MD 21224, USA. Electronic address: jcadet@intra.nida.nih.gov.
3 Neurobiological Psychiatry Unit, Department of Psychiatry, McGill University, Montreal, QC, H3A1A1, Canada; McGill University Health Centre, McGill University, Montreal, QC, H4A 3J1, Canada. Electronic address: gabriella.gobbi@mcgill.ca.
4 Department of Chemistry, University of California, Davis, Davis, CA 95618, USA; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, Sacramento, CA 95817, USA; Center for Neuroscience, University of California, Davis, Davis, CA 95618, USA; Institute for Psychedelics and Neurotherapeutics, University of California, Davis, Davis, CA 95616, USA. Electronic address: deolson@ucdavis.edu.
5 Karuna Therapeutics, Boston, MA, USA. Electronic address: syohn@karunatx.com.
6 Department of Pharmacology, Physiology and Neuroscience, School of Medicine Columbia, Columbia, SC, USA. Electronic address: Daniel.Foster@uscmed.sc.edu.